Claudio CAFIERO,Leonardo ORTENZI,Francesca J. SCHIARETTI
申请号：
US16113026
公开号：
US20180360849A1
申请日:
2018.08.27
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Dry powder formulations for inhalation containing a combination of an anti-cholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of an inflammatory and/or obstructive airways disease.
